Jane Larkindale

Jane Larkindale is the current Vice President of Clinical Science at PepGen. Prior to their current position, they were with Friedreich's Ataxia Research Alliance, NMD Consulting, and Critical Path Institute (C-Path). Jane has also been with the Muscular Dystrophy Association in the past. Jane holds a Bachelor's degree from the University of Arizona.

Jane Larkindale holds a DPhil in Plant Sciences from the University of Oxford, and a BSc (hons) in Plant Biotechnology and Physics from the University of Otago.

They work with Jeffrey Foy - VP, Toxicology, Michelle Mellion - SVP & Head, Clinical Development, and Jennifer Cormier - SVP, Clinical Operations. Jane Larkindale reports to James McArthur, President & CEO.